Metagenomi Therapeutics (MGX) Prepaid Assets (2023 - 2026)

Metagenomi Therapeutics (MGX) has 4 years of Prepaid Assets data on file, last reported at $4.4 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $4.4 million, down 29.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 29.25% YoY), and the FY2025 annual result was $4.4 million, down 47.19% from the prior year.
• Prepaid Assets slipped to $4.4 million in Q1 2026 per MGX's latest filing, from $4.4 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $8.4 million in Q4 2024 and troughed at $4.4 million in Q1 2026.
• A 4-year average of $5.8 million and a median of $5.9 million in 2024 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 80.95% in 2024, then tumbled 47.19% in 2025.
• A 4-year view of Prepaid Assets shows it stood at $4.6 million in 2023, then surged by 80.95% to $8.4 million in 2024, then tumbled by 47.19% to $4.4 million in 2025, then fell by 0.86% to $4.4 million in 2026.
• Business Quant data shows MGX's Prepaid Assets at $4.4 million in Q1 2026, $4.4 million in Q4 2025, and $4.7 million in Q3 2025.